Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Exelixis Inc. Common Stock (EXEL) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance

Exelixis Inc. Common StockTrade
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade

Price performance (Past 24H)

Key statistics

Exelixis Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 4× Exelixis Inc. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.

EXELTAK
Market Cap
$14.62B$58.74B
Volume
2,684,9573,110,994
Sector
HealthHealth
52-Week High
$59.13$19.05
52-Week Low
$34.54$13.23
Typical Hold Time
1 Days1 Days
Enterprise Value
$13.95B$86.65B
Dividend Yield
—3.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Exelixis Inc. Common Stock

Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.

Read more on EXEL →

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →